TCG Crossover Management’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.24M | Sell |
735,184
-688,458
| -48% | -$3.97M | 0.48% | 31 |
|
|
2025
Q1 | $9.4M | Hold |
1,423,642
| – | – | 1.28% | 25 |
|
|
2024
Q4 | $12.4M | Hold |
1,423,642
| – | – | 1.21% | 27 |
|
|
2024
Q3 | $27.8M | Hold |
1,423,642
| – | – | 2.36% | 18 |
|
|
2024
Q2 | $29.3M | Hold |
1,423,642
| – | – | 3.06% | 13 |
|
|
2024
Q1 | $30.4M | Hold |
1,423,642
| – | – | 2.4% | 19 |
|
|
2023
Q4 | $20.5M | Hold |
1,423,642
| – | – | 2.27% | 19 |
|
|
2023
Q3 | $13M | Hold |
1,423,642
| – | – | 1.91% | 20 |
|
|
2023
Q2 | $15.1M | Hold |
1,423,642
| – | – | 2.47% | 12 |
|
|
2023
Q1 | $17.4M | Hold |
1,423,642
| – | – | 3.39% | 12 |
|
|
2022
Q4 | $17.7M | Buy |
1,423,642
+75,000
| +6% | +$931K | 3.12% | 13 |
|
|
2022
Q3 | $18.4M | Buy |
1,348,642
+181,000
| +16% | +$2.47M | 5.53% | 7 |
|
|
2022
Q2 | $21.4M | Buy |
1,167,642
+661,219
| +131% | +$12.1M | 9.09% | 4 |
|
|
2022
Q1 | $8.14M | Buy |
+506,423
| New | +$8.14M | 3.27% | 12 |
|